FDA New Molecular Entity Approvals Rebound In 2004; Lyrica Is Fitting Finale
FDA's new molecular entity drug approval tally for 2004 represents a five-year high for the agency
FDA's new molecular entity drug approval tally for 2004 represents a five-year high for the agency